Paul, Weiss advised private equity firm GrowthCurve Capital on its majority investment in TailorMed, which operates the United States’ largest and most diverse network of resources to help patients access, afford and adhere to prescribed medications. The investment will enable TailorMed to expand its reach and portfolio of AI-powered solutions for providers, pharmacies and patients.
The Paul, Weiss team was led by corporate partners Christopher Machera and David Hong, and associate Tyler Isaman, and included partners Thomas de la Bastide and Steven Kaye; executive compensation partner Linda Barrett; tax partners Robert Killip and Matthew Jordan; and intellectual property partner Chuck Googe.
Related Insights
November 02, 2026